Krka, d. d. (LJSE:KRKG)

Market Cap	7.79B +45.9%
Revenue (ttm)	2.08B +7.2%
Net Income	372.00M -9.3%
EPS	11.98 -10.3%
Shares Out	30.31M
PE Ratio	21.46
Forward PE	19.23
Dividend	9.10 (3.54%)
Ex-Dividend Date	Jul 21, 2026

Volume	1,062
Average Volume	2,865
Open	258.00
Previous Close	258.00
Day's Range	254.00 - 258.00
52-Week Range	174.00 - 260.00
Beta	0.42
RSI	75.78
Earnings Date	May 14, 2026

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabo...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 11,667
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2025, Krka, d. d.'s revenue was 2.04 billion, an increase of 6.89% compared to the previous year's 1.91 billion. Earnings were 403.24 million, an increase of 12.96%.